Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of glimepiride for the treatment of neonatal diabetes mellitus caused by a novel mutation of the ABCC8 gene.

Journal of pediatric endocrinology & metabolism : JPEM - 16 Dec 2020

Qin Xiao, Zhong Jingzi, Lan Dan

Abstract excerpt

OBJECTIVES: Neonatal diabetes mellitus (NDM) is a rare form of monogenic diabetes that is usually diagnosed in the first six months of life. CASE PRESENTATION: We report on a male infant with neonatal diabetes who presented with diabetic ketoacidosis at two months and 16 days. A novel homozygous missense mutation (c.259T>G) was identified in the ABCC8 gene. In this case, insulin was replaced with glimepiride at a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Hypoglycemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant

Share to Infant, Newborn

Share to Mutation

Share to Prognosis

Share to Sulfonylurea Compounds

Share to Sulfonylurea Receptors

Source

Identifiers

PMID: 33035187
DOI: 10.1515/jpem-2020-0030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of glimepiride for the treatment of neonatal diabetes mellitus caused by a novel mutation of the ABCC8 gene.PMID 33035187Read ↗

Transient neonatal diabetes due to a disease causing novel variant in the ATP-binding cassette subfamily C member 8 (ABCC8) gene unmasks maturity-onset diabetes of the young (MODY) diabetes cases within a family.Semantic proximity Read ↗

A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.Semantic proximity Read ↗

A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation.Semantic proximity Read ↗

Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.Semantic proximity Read ↗

ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?Semantic proximity Read ↗

Permanent neonatal diabetes mellitus: same mutation, different glycemic control with sulfonylurea therapy on long-term follow-up.Semantic proximity Read ↗

Permanent neonatal diabetes mellitus due to an ABCC8 mutation: a case report.Semantic proximity Read ↗

Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy.Semantic proximity Read ↗

[ABCC8 gene analysis, treatment and follow-up of an infant with neonatal diabetes mellitus].Semantic proximity Read ↗

Genotype and Phenotype Heterogeneity in Neonatal Diabetes: A Single Centre Experience in TurkeySemantic proximity Read ↗

Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.Semantic proximity Read ↗

Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.